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Abstract
The compliance of patients to solid oral dosage forms is heavily conditioned
by the perceived ease of swallowing, especially in geriatric and pediatric pop-
ulations. This study proposes a method, based on an in vitro model of the
human oropharyngeal cavity, to quantitatively study the oral phase of human
swallowing in presence of single or multiple tablets. The dynamics of swallow-
ing was investigated varying the size and shape of model tablets and adjusting
the applied force to the mechanical setup to simulate tongue pressure variations
among individuals. The evolution of the velocity of the bolus, the oral transit
time, and the relative position of the solid oral dosage form within the liquid
bolus were measured quantitatively from high speed camera recordings. When-
ever the solid dosage forms were big enough to interact with the walls of the in
vitro oral cavity, a strong effect of the volume of the medication in respect of
its swallowing velocity was observed, with elongated tablets flowing faster than
spherical tablets. Conversely, the geometrical properties of the solid oral dosage
forms did not significantly affect the bolus dynamics when the cross section of
the tablet was lower than 40% of that of the bolus. The oral phase of swal-
lowing multiple tablets was also considered in the study by comparing different
sizes while maintaining a constant total mass. The predictive power of different
theories was also evaluated against the experimental results, providing a mech-
anistic interpretation of the dynamics of the in vitro oral phase of swallowing.
These findings and this approach could pave the way for a better design of solid
oral medications to address the special needs of children or patients with swal-
lowing disorders and could help designing more successful sensory evaluations
and clinical studies.
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1. Introduction
Deglutition is a fast and complex process, involving bolus transport from
the oral cavity to the esophagus without compromising the functionality of the
airway. From the clinical perspective, swallowing is usually divided into an oral
phase, a pharyngeal phase and an esophageal phase that are subsequent but non-5
independent from one another (Leonard and Katerine, 2008). The swallowing
reflex is first triggered by the motion of the tongue and is then accomplished by
involuntary nerve impulses that provide protection of the airway. The bolus is
safely guided through the glossopalatal junction (GPJ) to the upper esophageal
sphincter (UES), where progressive peristaltic contractions lead it through the10
esophagus to the lower esophageal sphincter (LES). The overall process, starting
from the first preparatory phase, in which the food bolus is chewed and wetted
with saliva, until the latter esophageal phase, involves the motion of more than
40 pairs of intrinsic and extrinsic muscles (Groher, 2016). Swallowing is therefore
a precisely timed process and the typical transit times for a liquid bolus to pass15
through the pharynx is of the order of 2 seconds, while it takes less than 6
seconds to reach the stomach (Brotherman et al., 2004). While reviewing the
mechanisms controlling swallowing, the roles of the tongue and the laryngeal
musculature, in ensuring the correct pressure driving force to allow for a safe
swallow, have been highlighted (Groher, 2016). In particular, the importance of20
lingual coordination in the preparatory and oral phase of deglutition cannot be
underestimated: the high mobility of the tongue, ensured by its set of extrinsic
and intrinsic muscles, gives it several degrees of freedom to shape, hold and
ultimately propel the bolus into the oropharynx.
Lack of tongue coordination can therefore lead to an alteration of the normal25
swallowing sequence that can compromise part of the time sequence of mech-
anisms held in place to protect the trachea from food and liquid penetration.
Patients affected by swallowing disorders have to strictly control their eating
habits, for instance by properly adjusting the texture of the food and drinks
consumed. The correct oral drug therapy for these patients, for which comor-30
bidities are common, has to deal with the low acceptance for classical solid
oral dosage forms that could become trapped in the larynx folds, leading to a
potential risk of choking and triggering local inflammations, esophagitis, and
ulceration (FDA, 2013). Similar challenges in the oral administration route of
solid formulations are interestingly found also in different age subsets, such as35
adolescents and pediatric populations for which the swallowing threshold has
to be considered by both the practitioner and the caregiver (Liu et al., 2014;
Stegemann et al., 2012; Mistry and Batchelor, 2017).
Although oral formulations and novel solid oral dosage forms, such as orodis-
perisble and mucoadhesive tablets, have been developed and commercialized,40
capsules and tablets still remain the most common oral drug delivery forms
(FDA, 1997; Slavkova and Breitkreutz, 2015), by virtue of the longer stability
of the active pharmaceutical ingredient (API) and the higher standardization of
the tableting process. The practice of dispersing crushed tablets into thickened
liquids, jelly, or food, can however change significantly the pharmacokinetics45
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and bioavailability of some solid oral dosage forms (Salmon et al., 2013; Stubbs
et al., 2008; Fields et al., 2015; Manrique et al., 2014; Radhakrishnan, 2016).
Size and shape are deemed the most important reasons that limit accept-
ability of solid oral dosage forms (FDA, 2013; Schiele et al., 2015). Aspiration
and choking during the oropharyngeal phase of deglutition become increasingly50
common with increasing the size of solid oral dosage forms (Kelly et al., 2010).
Studies revealed that the level of acceptability of an oral medication, albeit
dependent upon the age subset, is greatly reduced when its diameter is above
8 mm (Brotherman et al., 2004). It has also been shown that size is a major
player in determining the esophageal transit time, smaller tablets flowing faster55
(Brotherman et al., 2004; Yamamoto et al., 2014; Liu et al., 2014). Concerning
the dynamics of the pharyngeal phase of swallowing, no significant variations
were observed when swallowing small enough solid oral dosage forms (d=2 mm)
compared to the case of swallowing homogeneous liquids (Ren et al., 1996).
There is however a comparable lack of studies on the effect of size of tablets on60
the duration of the oral phase of swallowing. The role of tongue propulsion in
the first stages of deglutition was briefly discussed by Yamamoto et al. while
investigating the behavioral performance of swallowing tablets in 12 subjects.
In their report, the authors speculated that the difference in flow rate between
tablets and liquid vehicle may be the cause for the failure of the first swallowing65
attempt, leading the patient to take further sips to correctly transfer the oral
medication from the oral cavity to the esophagus (Yamamoto et al., 2014). Hey
et al. also found that administration of solid oral prescriptions in a single swal-
low might more easily leave the tablet lag the pharynx, while taking an identical
solid dose while drinking 100 mL of water effectively reduces the transit time of70
the tablet (Hey et al., 1982). The difficulty in tablet swallowing and the delay
in their organogastric transit is much accentuated by the potential inability of
some patients to drink larger amount of water or drinks in large sips (Stegemann
et al., 2012).
Other than size, particle shape is also very important factor to be considered75
in tablet design. Previous reports suggest that prolate (i.e. axially elongated)
tablets are easier to swallow and have faster esophageal transit times than oblate
(i.e. flattened) for the same delivered dose of medication (Hey et al., 1982;
Schiele et al., 2015; Liu et al., 2014) and capsules are generally preferred to and
tablets (Overgaard et al., 2001). On the other hand, it was also observed that80
more elongated tablets and capsules have a greater tendency to adhere and stick
to the esophageal epithelium than biconvex and less elongated tablets, hence
increasing the risk of irritating the esophageal mucosa (Wilson et al., 2000).
Behavioral tests seem however to suggest the preference of panelists towards
oblong shapes which has not yet been mechanistically explained in terms of oral85
dynamics.
Factors such as density and surface coating were also among the factors
considered to study the swallowability and the esophageal transit of tablets
and capsules (Liu et al., 2014). Channer and Virjee showed that the esophageal
transit time of capsules size 0, measured with the patients in a standing position,90
noticeably decreased when increasing their filling density (Channer and Virjee,
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1986) while Kasashi et al. found no statistical significant difference in the oral
transit times in respect of the density for small (0.24 mL) and medium sized
(0.60 mL) capsules (Kasashi et al., 2011). In general, several reports have
proved tablet coating improves the acceptability in patients (Liu et al., 2014).95
Hey et al. were among the first to demonstrate that small coated oval tablets
are swallowed more easily than uncoated oval tablets when consumed with an
equal volume of water (Hey et al., 1982). The type of film coating can also
greatly affect the tendency for solid oral formulations to adhere to the esophageal
epithelium as reported in several in vitro studies (Wilson et al., 2000; Liu et al.,100
2014). Furthermore, coating also can affect other factors that contribute to
patient acceptance, such as palatability and smell. The latter being a factor of
paramount acceptance of solid oral dosage forms in children, as several aids have
been developed ranging from in situ coating for tablets to lubricating flavored
gels containing glycerol to be applied to the back of the mouth prior to taking105
the medication (Diamond and Lavallee, 2010).
Finally, Lopez et al. highlighted the need for quantitatively assessing the
ease of swallowing of novel types of solid oral dosage forms, such as mini-tablets
and granulates, that specifically aim at optimally tailoring the dose of API to
pediatric and adolescent patients’ body weight or age (Lopez et al., 2015). Oral110
liquid formulations indeed constitute the most widely used oral forms in pedi-
atrics (Liu et al., 2014). Preliminary clinical studies showed a non-significant
difference in acceptability in newborns between a 15% glucose syrup and a sin-
gle mini-tablet of d=2 mm (Klingmann et al., 2015). In the report however
the volume and rheology of the suspending liquid vehicles was not discussed in115
relaxation to that of the syrup. Another clinical research showed that small
tablets (d=3 mm) can be easily swallowed by children from 2 to 6 years of age
(Thomson et al., 2009). A study involving 124 children aged 6 to 11 years, also
demonstrated a high acceptability towards ingestion of a flat round tablet of d=7
mm, especially upon training (Meltzer et al., 2006). Swallowing performance of120
multiple tablets in children has been subject of few studies, as reviewed by Mis-
try & Batchelor (Mistry and Batchelor, 2017). It was shown that the acceptable
number of tablets per unit dose depends both on the diameter of the tablet and
the age of the patient (Mistry and Batchelor, 2017; Kluk et al., 2015). Improve-
ment in children compliance when taking mini-tablets was achieved dispersing125
the tablets into flavored liquids jelly, as proposed by Jaganiet al. (Jagani et al.,
2016) and Kluk et al. (Kluk et al., 2015). However the same study, although
confirming the high palability of mini-tablets, showed lower acceptability and a
higher occurrence of chewing when the number of mini-tablets (d=3 mm) was
increased (Kluk et al., 2015). Hayakawa et al. showed that the ease of swallow-130
ing of multiple tablets as a unit dose decreases with their number, in particular
administration of a single conventional tablet of d=8 mm was perceived easier
to swallow than an identical mass of 10 mini-tablets (Hayakawa et al., 2016).
Based on all these premises, this study aims at presenting a novel method to
quantitatively assess the role of the physical properties of tablets, such as their135
size, shape and number, on the oral dynamics of swallowing. In order to lay the
basis for a mechanistic understanding of these phenomena, the study considered
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an in vitro model of the oral cavity which had been previously validated against
in vivo measurement while evaluating the effect of bolus rheology (Hayoun et al.,
2015; Mowlavi et al., 2016).140
2. Materials and methods
2.1. Materials
Different sizes and shapes of hard particles, representative of solid oral dosage
forms, were considered to compare the relative difference in the measured in
vitro oral transit time and bolus velocity. The effect of size for different solid145
oral dosage forms was studied using calibrated polypropylene spheres (The Pre-
cision Plastic Ball Company Ltd, Addingham, UK) of diameter ranging from
4.8 to 10 mm and smooth surface finishing. By using those model shapes the
degree of freedom of initial particle orientation in respect of the bolus was re-
moved, allowing for generalization of the results. More realistic model shapes of150
pharmaceutical tablets were instead used to assess the impact of the solid oral
medication geometry on the oral flow. These consisted of ellipsoids of revolu-
tion with volumes comparable to either a 8 mm or a 10 mm sphere (Table 1).
To this extent, elongated particles were designed and 3D printed by UV curing
(ProJectMJP 3600, 3D Systems Inc., San Diego, CA, USA). The shape of both155
flattened (i.e. oblate) and elongated (i.e. prolate) spheroids was consistently
described through their aspect ratio (AR), defined by the ratio of polar and
equatorial semiaxis (Fig 1). Density was measured by gas pycnometry (Accu-
Pyc pycnometer 1330, Micrometrics Instrument Corp., Norcross, GA, USA) for
both spherical and elongated tablets, obtaining values of ρS=850 ± 50 kg m−3160
and 1100 ± 50 kg m−3 respectively. The impact of tablet density in the oral
swallowing dynamics was not considered an important experimental variable as
previous in vivo studies already proved (Kasashi et al., 2011). Similarly, the
specific density of different liquid vehicles was tested in vitro without showing
any significant variation in the bolus velocity (Mowlavi et al., 2016).165
Moreover, in order to further explore the dynamics of swallowing of elongated
solid oral dosage forms, empty hydroxypropylmethyl cellulose (HPMC) capsules
size 00 and size 3 were purchased from Bulk Powders (Sports Supplements Ltd,
Colchester, Essex, UK) and filled with sucrose so that their density would match
that of the spherical beads (ρS=850 ± 50 kg m−3). The volume of a d=8 mm170
sphere is comparable to a size 3 capsule and the volume of a d=10 mm sphere is
almost double. A much bigger size 00 capsule was also considered as a limiting
case, given that it is the maximum capsule size recommended by the Food and
Drug Administration (FDA, 2013).
To assess the dynamics of the bolus in presence of multiple tablets, exper-175
iments were also run with several mono-dispersed spheres. In this set of tests,
the number of solid oral medications was varied while maintaining constant the
solid volume fraction of φ = 0.08 v/V, corresponding to the dose of a single
d=10 mm spherical tablet.
Glycerol (Sigma-Aldrich, CAS Number 56-81-5) was primarily used as liq-180
uid carrier, although a number of tests were also carried out using orange juice
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Table 1: Geometry of the solid oral dosage forms used in the in vitro experiments to model
swallowing of a single solid oral dosage form.
Tablet
shape
Characteristic
size (d or L x H)
Tablet to bolus
cross section
Volume Weight
Sphere d=4.8 mm 15 % 0.06 mL 50 mg
Sphere d=6.4 mm 28 % 0.13 mL 120 mg
Sphere d=8 mm 44 % 0.27 mL 240 mg
Effect of
tablet size
Sphere d=10 mm 68 % 0.52 mL 460 mg
Oblate
spheroid
12.7 x 3.2 mm
AR=0.25
28 % 0.27 mL 310 mg
Prolate
spheroid
10.5 x 6.9 mm
AR=1.5
33 % 0.27 mL 310 mg
Prolate
spheroid
14.7 x 5.9 mm
AR=2.5
24 % 0.27 mL 310 mg
Prolate
spheroid
18.4 x 5.3 mm
AR=3.5
19 % 0.27 mL 310 mg
Effect of
tablet shape:
volume of
0.27 mL
Capsule
size 3
15.5 x 5.8 mm
AR=2.80
22 % 0.27 mL 280 mg
Oblate
spheroid
15.8 x 3.9 mm
AR=0.25
42 % 0.52 mL 610 mg
Prolate
spheroid
13.1 x 8.7 mm
AR=1.5
52 % 0.52 mL 610 mg
Prolate
spheroid
18.4 x 7.4 mm
AR=2.5
37 % 0.52 mL 610 mg
Effect of
tablet shape:
volume of
0.52 mL
Prolate
spheroid
23.1 x 6.6 mm
AR=3.5
30 % 0.52 mL 610 mg
Effect of
tablet shape
Capsule
size 00
32.5 x 8.5 mm
AR=2.80
49 % 0.95 mL 900 mg
Figure 1: From left to right different shapes of solid oral dosage forms considered: a) sphere b)
oblate spheroid of AR=0.25, c) prolate spheroid of AR=1.5, d) prolate spheroid of AR=2.5,
e) prolate spheroid of AR=3.5, f) capsule size 3. The arrow points the direction of swallowing.
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from concentrate (Tesco Stores Ltd., Welwyn Garden City, Hertfordshire, UK).
In both cases traces of a red dye (0.02 % w/w) were added to enhance the image
contrast. The density of the two liquids were measured using a graduated cylin-
der obtaining values of ρL=1250± 20 kg m−3 and 1040± 30 kg m−3 for glycerol185
and orange juice respectively. The liquid volume used in the experiments was 6
mL, consistently with previous studies (Hayoun et al., 2015) and comparable to
in vivo values reported in literature (Alsanei, 2015; Kluk et al., 2015). All the
experiments were performed at 22± 1°C and, at this temperature, the rheology
of the two liquid vehicles was characterized in compliance with ISO standard190
3219 with a controlled stress-controlled rheometer (Model UDS 200, Paar Phys-
ica, Germany). Both the glycerol solution and the orange juice exhibited a
Newtonian behavior over the range of shear rates considered (1− 500 s−1) and
their viscosity was µ=1.05±0.05 Pa s and µ=0.03±0.01 Pa s respectively.
2.2. The in vitro swallowing model195
The experimental setup used to study the oral phase of swallowing simplified
the in vivo flow pattern considering a bi-dimensional projection in the sagittal
plane. A thin, flat and freely deformable membrane, obtained by sealing to-
gether two polyethylene (PE) sheets, was stuck to the rigid surface mimicking
the human palate, and used to constrain and hold the bolus. The propulsion200
of the bolus was instead generated by a roller, sealing anteriorly the membrane
filled with the liquid and the solid oral dosage forms. The thin membrane and
the roller provided together the two lingual functions of bolus containment and
propulsion. The rigid roller was supported by a pivoting arm, attached to a re-
volving shaft driven through a set of hanging weights, as schematically depicted205
in Fig. 2. Upon triggering of the experiment, the roller moves, following the
curved path, squeezing the liquid bolus through the PE membrane. A theoreti-
cal model, derived in Appendix A, was used to describe the dynamics of the in
vitro setup and relate the velocity of the bolus tail to the rheology of the liquid
carrier and the size and number of solid oral dosage forms. Variability of tongue210
applied pressure among individuals was accounted for by adjusting the weight
driving the rotation of the pivoting arm. In this study roller driving forces (F)
of 2, 2.7, and 4 N were used, corresponding to applied torques of 57, 73 and
108 mNm respectively. These driving forces generated maximum pressures on
the bolus tail of approximately 11, 15, and 21 kPa, consistently with in vivo215
data from the literature (Hayoun et al., 2015). Results from the same in vitro
model were successfully validated against in vivo ultrasound measurements with
thickened fluids (Mowlavi et al., 2016) and the swallowing simulator matched
well the in vivo bolus dynamics when applying a force of 2 N.
2.3. Methods220
The different solid oral dosage forms listed in Table 1 were first incorpo-
rated into the suspending liquid carrier and subsequently the bolus was pushed
manually into the membrane through its anterior opening (Fig. 2). The initial
position of the tablets in the bolus is essentially dictated by buoyancy as the
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Figure 2: Schematics of the in vitro setup.
density of the model tablets is lower than that of the suspending liquid vehicle.225
Solids were located centrally within the bolus cross section in order to avoid
direct contact with the walls of the membrane. Moreover, non spherical tablets
and capsules were consistently aligned with the longitudinal axis of the bolus,
in order to present their smallest cross section in the direction of swallowing
(Fig. 1).230
The roller movement was triggered by releasing a pin and lateral images
were recorded using a fast camera (model ac1920-155 um, Basler, Germany) at
150 frames per second. The dynamics of the bolus was measured from the video
recordings: image processing tools were used to extract the instantaneous posi-
tion of the roller (corresponding to the bolus tail), of the bolus center of mass,
of the tablet center of mass, and to measure the bolus area. The instantaneous
velocity of the roller was calculated from the time dependent roller positions by
numerical differentiation. Results were compared to the theoretical predictions
obtained considering the system dynamics and the drag force defined in Eq. A.8
and A.9. Finally, the relative position of the solid oral dosage forms within the
bolus was quantified by the difference (∆θ) of the angular positions of the bo-
lus tail and of the tablet, as schematically illustrated in Fig. 2. Decreasing ∆θ
indicated that the tablet was slower than the liquid carrier and moved towards
the tail of the bolus, while constant ∆θ indicated that it moved at the same
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velocity as the rest of the bolus.
∆θ = θtablet − θroller (1)
Three repeats, in randomized order, were taken per each set of experimental
variables to assess the variability and robustness of the in vitro setup to external
disturbances, such as slight variations in the initial position of the solid oral
dosage forms within the liquid bolus, or minor differences in the shape of the
PE membranes.235
3. Results and discussion
The experiments aimed at understanding the effect of solid oral dosage size,
shape and number on the oral swallowing dynamics while varying the external
applied force.
3.1. In vitro swallowing of single tablets240
The effect of tablet size on the dynamics of the mechanical system was ini-
tially investigated. The applied force and the initial position of the spherical
tablet were consistent in all experiments, as illustrated in Fig. 3 and the charac-
teristic oral transit time was extracted from the experimental video recordings,
marking the frame at which the front of the peristaltic flow left the plastic mem-245
brane (front out-FO) and the instant at which the roller hit the stopper leading
the tail of the bolus to exit the plastic membrane (tail out-TO). Average val-
ues and standard deviations were computed based on three repetitions of each
experiment, as listed in Table 2.
From the snapshots in Fig. 3 and the data listed in Table 2, it can be250
seen that larger solid oral dosage forms had a slightly delayed FO and TO
with respect of smaller spherical tablets. More generally, the delay between
these events both depended on the size of solid oral dosage forms and on the
applied load to the system. The range of values for the characteristic in vitro
swallowing listed in Table 2 well compares with the typical values of oral transit255
times reported in literature when considering swallow of homogeneous thickened
fluids. When considering administration of solid oral dosage forms, only a few
references are found in literature: Kasashi et al. provide slightly longer oral
transit times (1.14-2.23 s), based on videofluoroscopy assessment of capsule
swallowing (Kasashi et al., 2011), while EMG recordings from Yamamoto et al.260
show a one-fold increase in the swallowing duration when taking a large d=9
mm biconvex tablet compared to the water control (Yamamoto et al., 2014),
but a less significant increase for smaller tablets.
The velocity profiles obtained after numerical differentiation of the time
dependent roller angular positions are plotted in the following figures until bolus265
front out (FO), consistently to the approach followed by Hayoun et al. (Hayoun
et al., 2015).
The results obtained with different solid oral dosage forms shapes and sizes
were compared to the theoretical predictions obtained considering the system
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Figure 3: Screenshots of in vitro experiments using a 2 N load, a 1.05 Pa s Newtonian liquid
carrier and single spherical tablets having different diameters. The pictures in the third and
fourth columns are respectively taken when the bolus front leaves the membrane (FO) and
when the tail of the bolus leaves the membrane (TO).
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Figure 4: Roller velocity profiles for model spherical tablets of d=4.8, 6.4, 8.0 and 10 mm
using a 2 N load and a 1.05 Pa s Newtonian liquid carrier. Theoretical curves are obtained
using Eq. A.8.
dynamics and the drag force defined in Eq. A.8 and illustrated in the charts270
with thin lines.
Variations in the driving load applied to the mechanical device strongly
conditioned the bolus dynamics, as discussed by Hayoun et al. (Hayoun et al.,
2015). The combined effect of applied force and size for spherical solid oral
dosage forms is illustrated in Fig. 4 and Fig. 5: experiments at low applied forces275
(2 N) were characterized by an inertial regime, in which the angular velocity
was almost linearly increasing in time, followed by a viscus regime where the
drag force became predominant and effectively equilibrated the inertial force,
leading to asymptotic values of bolus velocity (Fig. 4). By contrast, experiments
at higher applied loads only showed the inertial regime.280
The relative importance of the additional drag force induced by the pres-
ence of swallowed solids is also dependent upon the external load applied to the
system. Experiments in the lowest load configuration (2 N) showed a moderate
decrease of swallowing velocity and longer oral transit time increasing the diam-
eter of the suspended spherical solids. Small solid oral dosage forms were also285
found not to significantly alter the system dynamics, compared with the solid-
free case presented by Hayoun et al., as can be appreciated from the profiles
reported in Fig. 4 and 5.
Conversely, tests with significantly bigger model tablet seem to suggest the
onset of an anticipated viscous regime of significantly low angular velocity than290
the asymptotic values reached in clear liquid. This is especially visible at low
applied forces, as illustrated in Fig. 4. Conversely, at the highest load (4 N),
no significant effect of the tablet diameter was observed, although the in vitro
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Figure 5: Roller velocity profiles for model spherical tablets of d=6.4, 8 and 10 mm at 2.7
and 4 N load and a 1.05 Pa s Newtonian liquid carrier. Theoretical curves are obtained using
Eq. A.8.
Table 2: Characteristic oral transit times measured with the mechanical model when swal-
lowing a single spherical tablets in a 1.05 Pa s liquid carrier (glycerol).
Applied force Tablet diameter
Average bolus FO
(SD n=3)
Average bolus TO
(SD n=3)
4.8 mm 0.58 (0.03) s 0.73 (0.02) s
6.4 mm 0.61 (0.04) s 0.78 (0.04) s
8 mm 0.64 (0.03) s 0.82 (0.02) s
2 N
10 mm 0.97 (0.17) s 1.27 (0.18) s
4.8 mm 0.45 (0.02) s 0.58 (0.01) s
6.4 mm 0.46 (0.02) s 0.59 (0.01) s
8 mm 0.47 (0.01) s 0.60 (0.01) s
2.7 N
10 mm 0.53 (0.03) s 0.66 (0.03) s
4.8 mm 0.34 (0.02) s 0.43 (0.03) s
6.4 mm 0.34 (0.02) s 0.43 (0.02) s
8 mm 0.33 (0.02) s 0.43 (0.01) s
4 N
10 mm 0.38 (0.01) s 0.48 (0.02) s
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transit time of the biggest sphere was still slightly slower than the others (Fig. 5).
In the case of an intermediate load (2.7 N), results showed a comparably slow295
dynamics of the d=10 mm spherical solid, when compared to the other beads.
The theory used to describe the viscous dissipation (Eq. A.8) captured well the
transition between inertial to viscous regimes in absence of significant solid-solid
interaction between the tablet and the sidewalls (i.e. smaller solids). Conversely,
a noticeable under-prediction of drag force was observed for the largest sphere300
at the lowest driving force where the friction between tablet and PE tube,
although mitigated by the lubricating effect of glycerol, played a significant role
in the swallowing dynamics (Fig. 4). This both outlines the limits of the simple
theoretical model assumed by the study and the relevance of using in vitro
experiments to evaluate the effect of different shapes of solid oral dosage forms.305
The examination of the relative motion of the tablet within the suspending
liquid vehicle was considered in light of the study of peristaltic model flows and
the experimental observation of Yamamto et al. that commented on the different
flow rate between liquid and solid portions of the swallowed bolus. The angular
distance between the position of the roller and the position of the center of mass310
of the tablet was quantified through the value of ∆θ. This parameter, not being
directly comparable to a specific theoretical formulation for the field of motion
here considered, leads to a more qualitative interpretation, compared to the
much more quantitative information obtained from the roller velocity profiles
of Fig. 4 and Fig. 6. Nonetheless the typical average profiles of ∆θ reported,315
as a function of the tablet size and applied load, in Fig. 8, give some coherent
results. The profiles show good consistency of initial positioning of the beads,
that were always placed in proximity to the bolus front with the sole exception
of the largest spherical tablet, that instead was positioned slightly rearward in
order to limit the occurrence of liquid leaking before triggering the experiment.320
At low applied force, Fig. 8 indicates that both the 6.4 and the 8 mm spherical
tablets did not move significantly within the bolus, as the initial angle was
preserved throughout the bolus trajectory. Conversely, a significant reduction
in ∆θ was observed in both the d=4.8 mm and d=10 mm spheres that lagged
toward the tail of the bolus. This result somehow confirms that small objects325
are less efficiently transported by peristalsis, as indicated in previous works in
that field (Fauci, 1992; Hung and Brown, 1976). On the other hand, the relative
backward motion of the biggest sphere, unexplained in terms of simple peristaltic
transport, is instead driven by the friction with the wall membrane. In this case
the liquid carrier, under the imposed squeezing action of the roller, was able330
to flow cross the free portion of the bolus unoccupied by the solid oral dosage
form lagging the spherical tablet behind. Increasing the external applied load
did not lead to significant changes in the tablet relative position: the smallest
solid still slides backwards, whist no noticeable variations in relative position in
respect of the bolus tail are observed for both the intermediate size spherical335
tablets (d=6.4 and the d=8 mm).
Based on these in vitro observations, the backward motion of the smallest,
or very large solids might limit the active volume of liquid available to wash
them out during the pharyngeal and esophageal phase of swallowing and also
13
cause them to be more easily perceived in vivo by the contracted part of the340
tongue propelling the bolus. Following this hypothesis, the extent of mechanical
solicitation on the tongue apex and dorsum will also be dependent upon the size
and density of the solid oral prescription and the level of its surface finishing.
The lack of comparable videofluoroscopy images does currently not allow to
confirm this claim, although the conclusion from Yamamto et al., seems to345
suggest that the difference between tablet and liquid vehicle velocity might
indeed lead to the need for repeated swallows to effectively wash the tablet
down the pharynx (Yamamoto et al., 2014).
The effect of shape was considered comparing results of spherical, oblate
(flattened) and prolate (elongated) solid oral dosage forms (Fig. 6). The orien-350
tation of the solids in respect of the longitudinal axis of the bolus was always
maintained throughout the oral trajectory. The corresponding theoretical ve-
locity profiles were in this case computed considering the cross sectional radius
of the tablet in the direction of swallowing as Ri in Eq. A.8.
The effect of tablet shape on the bolus dynamics was more significant when355
the mechanical system was operated under low applied forces, as already ob-
served when discussing the role of size for spherical solid oral dosage forms. In
this condition, the tablet and capsule geometry was found to affect more signif-
icantly the dynamics of larger solid oral dosage forms (Fig. 6). The set of data
from in vitro swallowing at constant volumetric dose of solid oral medications360
(equivalent to that of a d=10 mm sphere) showed that there was a correlation
between the cross sectional area of the swallowed solid and the rapidity of bolus
transport through the oral cavity (Fig. 6). As the cross section of the tablet fell
below 40% of that of the bolus, the effect of shape for spheroids became less
and less important (Fig. 6a). Naturally, the increased wall interaction observed365
when running experiments with the largest spherical tablet likely resulted in fur-
ther dissipation phenomena. Yet, the velocity profile of that solid oral dosage
form was nearly identical to that of a size 00 capsule, whose volume is notice-
ably larger than the sphere (Fig. 6b). This consideration allows to highlight the
importance of optimally choosing the solid oral dosage shape in the delivery of370
oral medications.
When considering the set of data from experiments with tablets of equivalent
volume to that of a d=8 mm sphere, it was found that the change in cross
section did not lead to significant variations in bolus dynamics. The role of
tablet shape became therefore marginal. This observation is in good agreement375
with the clustering of the velocity profiles observed in Fig. 6.
Increasing the driving force applied to the roller led to a faster bolus dy-
namics that was not strongly conditioned by the tablet shape, in that case the
oral transit times obtained for the elongated tablets (AR 3.5) were similar to
those of spherical tablets of identical volume. Moreover, the theoretical velocity380
profiles consistently over-predicted the experimental data of spheroidal solids.
This highlights the necessity for more accurate models to account for particle
shape, as the model of Eq. A.8 does not account for the length of the solid oral
dosage form in the direction of swallowing, but only considers its cross sectional
radius. in vivo the preference of patients towards different shapes of tablets385
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was comprehensively discussed by Overgaard et al. over a sample population
of 331 volunteers (Overgaard et al., 2001). Based on the evaluation scheme
proposed by the authors, a higher preference towards strongly arched circular
shapes was preferred over oblong shapes for small tablets (approx. volume of
0.16 mL), while for medium and large tablets (approx. 0.5 and 0.95 mL), ob-390
long and oval shapes were preferred over the flat circular. In particular, for
the biggest size subset, thick oval shapes (i.e. prolate ellipsoid with low aspect
ratios) were generally indicated as difficult to swallow, which is consistent to
the poor performance observed in vitro.
The high viscosity of glycerol is close to that of oral pediatric formulations,395
such as paracetamol suspensions (Batchelor et al., 2015). Thickened liquids and
jelly have also been used to aid tablet and mini-tablet swallowing in geriatric
and pediatric patients (Kluk et al., 2015; Mistry and Batchelor, 2017). In order
to assess the feasibility of using the proposed in vitro tests to characterize a
wider range of liquid carriers, a concentrated orange juice was also considered.400
The viscosity of this carrier is considerably lower than that of glycerol but still
approximately 30 times higher than water. The effect of the rheology of the
liquid carrier was assessed using the largest tablets and in the lowest load con-
figuration (2 N) to better capture the effect of tablet elongation, as highlighted
by the precedent trials in glycerol. Results show a noticeable decrease in the405
characteristic oral transit times (Table 3). The observation is consistent with
the findings of Mowlavi et al. who assessed the role of viscosity using diluted
glycerol solutions and a commercial food thickener (Mowlavi et al., 2016). Com-
paring the different liquids in terms of their rheology, the authors demonstrated
the transition from an inertial regime, characterized by a linearly increasing bo-410
lus angular velocity during swallowing, to a viscous regime of asymptotic values
of bolus velocity. Consistently to this finding, the velocity profiles obtained with
orange juice, illustrated in Fig. 7, remarkably differ from those of Fig. 6b. The
low viscous dissipation calculated in case of the concentrated juice predicts an
almost linear velocity profile not significantly dependent on the diameter of the415
tablet considered. Besides, experiments with concentrated juice demonstrated a
stronger impact of tablet elongation compared to the weak effect observed with
glycerol. Comparing the values listed in Table 3 with the velocity profiles Fig. 7
shows comparable transit times for the most elongated (AR 3.5) and the flat-
test (AR 0.25) tablets. Conversely, longer transit times, higher variability and420
lower bolus velocities were registered for the spheroidal tablet of largest cross
section (AR 1.5). A visual analysis of the corresponding tests helps identifying
the cause for a similar behavior in terms of tablet friction against the sidewalls.
Tablet shapes with smaller cross sections were found less likely to lag behind the
liquid vehicle therefore avoiding direct contact with the sidewalls. Conversely,425
tablets of large cross section (AR 1.5) pinch against the membrane. This results
in a non monotonic roller angular velocity profile and considerably TO times,
as reported in Table 3.
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Table 3: Characteristic oral transit times at 2 N load for different aspect ratios of spheroidal
tablets of equivalent volume to a d=10 mm sphere in glycerol and concentrated orange juice.
Liquid
vehicle
Tablet
AR
Average bolus FO
(SD n=3)
Average bolus TO
(SD n=3)
0.25 0.67 (0.09) s 0.92 (0.05) s
1.5 0.69 (0.06) s 0.95 (0.10) sGlycerol
3.5 0.65 (0.04) s 0.87 (0.04) s
0.25 0.31 (0.03) s 0.43 (0.02) s
1.5 0.39 (0.09) s 1.59 (0.35) sOrange juice
3.5 0.31 (0.02) s 0.42 (0.02) s
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Time (s)
Sphere d = 10 mm
Spheroid AR 0.25
Spheroid AR 1.5
Spheroid AR 2.5
Spheroid AR 3.5
HPMC capsule size 00
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HPMC capsule size 3
Theory: d = 8 mm
Theory: d = 5.3 mm
b)a)
Figure 6: Effect of tablet shape using a 2 N load in a 1.05 Pa s Newtonian liquid carrier:
roller angular velocity for oblate, spherical, and prolate tablets of identical volumes to that of
a d=8 mm (a) and d=10 mm sphere (b). Theoretical curves are obtained using Eq. A.8.
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Spheroid AR 3.5 µ=1.05 Pa s
Theory: d = 10 mm µ=1.05 Pa s
Figure 7: Effect of the carrier liquid vehicle viscosity at 2 N load when considering in vitro
swallowing of oblate (flattened) and prolate (elongated) spheroidal tablets of different aspect
ratio (AR 0.25, 1.5 and 3.5). Theoretical curves are obtained using Eq. A.8 for a tablet
diameter of 10 mm.
Figure 8: Angular distance between the bolus tail and the center of mass of spherical solid
oral dosage forms using a 1.05 Pa s Newtonian liquid carrier at respectively a) 2 N, and b)
2.7 N applied force.
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3.2. In vitro swallowing of multiple tablets
The relevant change in the measured in vitro oral dynamics was assessed430
when swallowing several tablets as a single unit dose. In these experiments
the amount of liquid vehicle was kept consistent with the previous trials and
the number of tablets was varied, according to their diameter, to deliver ap-
proximately an identical cumulative volume of solid oral medications. Beside a
realistic volume fraction of solid oral medications of φ=0.08 v/V, corresponding435
to a dose of 460-500 mg/6 mL, using the in vitro model also allowed considering
the effect of pushing the volume fraction to φ=0.15 v/V (920-960 mg/6 mL).
0 0.3 0.6 0.9
Time (s)
0
2
4
6
8
R
ol
le
r a
ng
ul
ar
 v
el
oc
ity
 (R
AD
 s-
1 )
d = 10  mm
d = 8 mm
d = 6.4 mm
d = 4.8 mm
Theory: φ = 0.08
F = 2 N
F = 2.7 N
F = 4 N
Figure 9: Effect of the particle size and applied force on the evolution of the angular velocity
with time, at constant solid volume fraction (φ=0.08 v/V) and using a 1.05 Pa s Netwonian
liquid carrier. Theoretical angular velocity profiles obtained from Eq. A.9.
Average velocity profiles at φ=0.08 v/V, obtained from three repetitions for
the different diameters and applied forces, are plotted in Fig. 9. The correspond-
ing characteristic transit times reported in Table 4. The oral dynamics at low440
volume fraction of suspended solids was not strongly conditioned by the size of
the spherical tablets when the system was operated under higher applied loads
(2.7 and 4 N). Decreasing the applied force to the mechanical system led to an
increase in the oral transit time with the volumetric dose of suspended solids
φ for the tablet diameters here considered. In particular, driving the system445
with a more physiologically representative 2 N load resulted in velocity profiles
that quickly reached a steady state where the viscous dissipation quantitatively
equilibrated the applied force (Fig. 9).
Increasing the suspended particle volume fraction to φ=0.15 v/V affected
more significantly the flow of smaller tablets and accentuated the viscous dissi-450
pation leading to a lower steady state velocity and a faster onset of the steady
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Table 4: Characteristic oral transit times when swallowing a fixed dose of spherical tablets of
different diameters in a 1.05 Pa s Newtonian liquid carrier.
Applied
load
Tablet
diameter
Number of
tablets
Average bolus FO
(SD n=3)
Average bolus TO
(SD n=3)
4.8 mm 9 0.69 (0.04) s 0.91 (0.04) s
6.4 mm 4 0.76 (0.07) s 1.01 (0.08) s
8 mm 2 0.75 (0.08) s 0.99 (0.09) s
2 N
10 mm 1 0.97 (0.17) s 1.27 (0.18) s
4.8 mm 9 0.48 (0.02) s 0.68 (0.03) s
6.4 mm 4 0.54 (0.04) s 0.73 (0.06) s
8 mm 2 0.50 (0.02) s 0.68 (0.03) s
2.7 N
10 mm 1 0.53 (0.03) s 0.66 (0.03) s
4.8 mm 9 0.35 (0.01) s 0.47 (0.02) s
6.4 mm 4 0.36 (0.02) s 0.47 (0.03) s
8 mm 2 0.45 (0.02) s 0.65 (0.03) s
4 N
10 mm 1 0.38 (0.01) s 0.48 (0.02) s
state. This suggests that the fluid-solid interaction in presence of multiple beads
increased significantly the drag force, hence leading to a reduction in the mea-
sured bolus velocity. This finding is somehow confirmed by the increased dura-
tion and area of the EMG bursts registered in vivo when swallowing multiple455
tablets, indicating the need for effortful swallows (Yamamoto et al., 2014).
Figure 10: Screenshots from the in vitro experiment using a 2 N load and multiple spherical
tablets (d=4.8 mm, φ=0.08 v/V) in a 1.05 Pa s Newtonian liquid carrier. Tablets moving
towards the bolus tail are circled.
The increase in apparent liquid carrier viscosity predicted through the Krieger-
Dougherty model (Eq. A.9) led to a slower theoretical dynamics, as can be ap-
preciated comparing the results presented in Fig. 9 with those of Fig. 4 and
Fig. 5. A good agreement between experimental results and theoretical val-460
ues was found at low suspended solids volume fraction, however the theoretical
model was incapable to capture the effect of particle size on the dynamics of the
system. The experiments demonstrated that this effect was more significant at
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low applied forces or when the suspended phase volume fraction was increased.
Image analysis revealed that when the size of the solid oral dosage was465
reduced, these moved towards the tail of the bolus. This effect is qualitatively
illustrated in Fig. 10 where clustering of suspended solids in proximity of the
roller can be observed. The buildup of solids close to the roller resulted in a
concentration gradient that limits the applicability of Eq. A.9, justifying the gap
between experimental data and theory. More sophisticated theoretical models470
are therefore needed to account for both the effect of solid oral dosage form
size and dose. Particle image velocimetry could be used to study the bolus flow
pattern, and numerical simulations, accounting for the full fluid-particle and
particle-particle interaction, should be considered to model more accurately the
dynamic system.475
In vivo, it can be speculated that the apparent backward motion of tablets,
flowing towards the tip of the tongue, might lead the patient to interrupt the
swallow or to masticate the tablets, instead of swallowing them whole. Studies
in children show that the occurrence of chewing increases with the administrated
amount of mini-tablets, as already demonstrated by Kluk et al. (Kluk et al.,480
2015). In another study, that compared the ease of swallowing of mini-tablets
(d=3 mm) in respect of a conventional tablets (d=8 mm), few of the healthy
young participants were not able to swallow 10 mini-tablets with a single sip
of water (Hayakawa et al., 2016). The result led the authors to conclude that
there is an optimal number of tablets above which the perceived attribute of485
ease of swallow with respect to conventional tablets deteriorates (Hayakawa
et al., 2016). This highlights the need for understanding the bolus internal fluid
dynamics in presence of multiple suspended particles that is key to support the
design of novel solid oral medications that are easier to swallow.
With respect to tablet size, in vivo data from literature does not currently490
allow to complement the in vitro observations as comparable videofluoroscopy
swallowing studies aiming at describing the dynamics of tablet swallowing are
scarce. In one of these studies Kasashi et al. compared the effect of size for two
different gelatin capsules (size 1 and size 4) and density (ρS=690−1370kg m−3)
together with the patients’ head position during swallowing (Kasashi et al.,495
2011). Their results indicate patient’s preference towards swallowing smaller
capsules that, irrespective of their density, lead to a statistically significant
reduction in the oral transit time of the solid medication. The authors therefore
suggest that the oral transit time may be effectively used to establish swallowing
preferences in patients (Kasashi et al., 2011). Numerous other sensory and500
hedonic reports have shown how the attribute of ease of swallowing for single
tablets consistently increases, decreasing the size of the solid oral dosage forms
(Liu et al., 2014). This observation is confirmed by the present experimental
study that shows the negligible impact of small tablets on the oral swallowing
dynamics (Fig. 4 and Fig. 5).505
Sensory trials with mini-tablets (d<4 mm) showed a higher acceptability in
children and newborns than other conventional types of oral delivery medica-
tions (i.e. syrup) (Liu et al., 2014; Klingmann et al., 2015; Mistry and Batchelor,
2017). This conclusion should however be put in relation to the viscosity of the
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different liquid vehicles used for tablet administration as it highly conditions510
the palatability and grittiness perception (Liu et al., 2014; Lopez et al., 2016).
Therefore, examination of oral transit of similar solid oral dosage forms against
liquid oral medicines would greatly benefit from a solid in vitro testing base.
An interesting future direction is to extend the in vitro experiment to con-
sider also the pharyngeal and esophageal phases of swallowing which would515
enable to assess more holistically the impact of tablet formulation on all stages.
Finally, modeling the complex physics of salivary lubrication and wall inter-
action although outside the aim of the present study could constitute an impor-
tant development in view of a more comprehensive description of wall friction
and adhesion with the oral mucosa, following notable examples of in vitro works520
dealing with tablet adhesion to the esophagus (Cook and Khutoryanskiy, 2015).
4. Conclusions
This study investigated the effect of the presence of a single or multiple solid
oral dosage forms in a peristaltic flow relevant for the oral phase of swallowing, to
improve the understanding of the mechanical phenomena governing swallowing525
of tablets and capsules. The effect of tablet size, shape, volume fraction, and
applied force were studied in a controlled and consistent way in an in vitro
model experiment. Results at low to medium applied loads demonstrated that
the dynamics of the bolus in presence of small, single spherical tablets did
not exhibit significant variations with respect to the theoretical predictions in530
absence of any suspended solids. Conversely, the flow was more consistently
slowed down when testing larger spherical tablets, especially at low driving
forces. Increasing the applied driving force reduced the effect of the diameter
of the swallowed solid and speeded up the dynamics.
The relative position between solid oral dosage forms and roller was also535
studied and it was found that small spherical solids steadily moved towards the
tail of the bolus, whilst slightly bigger tablets (d=6.4 and d=8 mm) conserved
their initial position relative to the bolus tail. Further increasing in the cross
sectional diameter of the spherical tablet increased its friction against the in
vitro oral cavity, ultimately causing the solid to lag behind the bolus. In vivo, it540
can be speculated that increased proximity with the tongue apex might result
in a stronger perception of the presence of the solid oral medication.
The effect of solid oral dosage shape was considered using spheroids of dif-
ferent aspect ratios but identical volumes to those of two calibrated spherical
tablets (0.27 and 0.52 mL). Experiments show that using solids with smaller545
cross sections speeded up the dynamics of the bolus. This effect was only ap-
preciable for the largest tablets and under low roller applied force, but it is
accentuated with low viscosity liquid carriers. In the case of single tablets, the
simple theoretical model proposed gives reasonably good predictions for small
particles, but fails to capture the complex phenomena occurring when consid-550
ering larger solid oral dosage forms, hence demonstrating the importance of
considering in vitro experiments.
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The in vitro oral phase of swallowing was significantly slowed down when
considering multiple suspended solids. Varying the size of the solid oral pre-
scription changes their ability to pack. While larger tablets tended to align in555
the direction of flow, smaller tablets could also pack more closely in the width
of the bolus. These differences limit the applicability of existing theories, in
particular at higher volume fractions of suspended solids and provide further
evidence supporting the use of in vitro experiments. Given the pharmaceutical
interest for new solid oral formulations, targeting the special needs of infants560
and elderly, the in vitro approach presented in this study could help screen-
ing novel formulations and help designing more targeted in vivo studies, before
running in vivo investigations.
Appendix A. Derivation of the theory
The flow in the esophagus has previously been modeled considering a peri-565
staltic flow in a duct (Brasseur, 1987; Li et al., 1990). In this type of geometry
the progressive contraction and relaxation of the sphincters provides the pressure
driving force for bolus transport. In the literature, the effect of peristaltic wave
shape, type of pumped fluid and presence of single or multiple suspended solids
have been investigated showing an increase in particle velocity and displace-570
ment with particle diameter (Fauci, 1992; Hung and Brown, 1976). Although
effective in modeling the simpler geometries of the esophagus and ureter, the
extension of the peristaltic flow assumption to the oral cavity during swallowing
finds several difficulties due to the more articulated lingual gestures. A simple
model was nonetheless developed to evaluate the effect of viscosity during the in575
vitro swallowing of liquids without any suspended solid (Mowlavi et al., 2016).
This mechanistic theory here synthetically considers the dynamics of the roller
and of the bolus, driven by the external applied load and slowed down by the
inertia and by the viscous dissipation in the bolus.
In the mechanical model used to simulate the oral phase of swallowing the580
total kinetic energy K is made up by: 1) the roto-translational motion of the
bolus (of mass mB , linear velocity vB , and inertia IB), 2) the hanging weight
(mass M and linear velocity vM ), and 3) the rotation of the central assembly, of
inertia I at angular velocity θ˙ (Eq. A.1). Linear velocities can be put in relation
to the angular velocity of the pulley θ˙, knowing the radial distances from the585
center of rotation rA and rP (see Fig.2).
K =
1
2
(mB v
2
B + IB θ˙
2) +
1
2
M v2M +
1
2
I θ˙2 (A.1)
The overall potential energy of the system U is calculated from the displace-
ment of the hanging mass and the vertical position of the bolus center of mass
(Eq. A.2).
U = M g θ rP +mB g rA sin(θ) (A.2)
Negative work on the system is done by the viscous dissipation Fd, tangential590
to the roller trajectory, and function of the angular velocity θ˙, the rheology of
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the liquid carrier µ and the geometry of the bolus. The equation of motion of
the mechanical system, characterized by the single degree of freedom of angular
rotation θ, is obtained from the Lagrange equations of dynamics, where Q is
the generalized force (Eq. A.4).595
d
dt
(
d
dθ˙
(K − U)
)
− d
dθ
(K − U) = Q (A.3)
Q = Fd · ∂x
∂θ
(A.4)
Substituting for K and U and after further rearrangement, an explicit re-
lation to obtain the roller angular acceleration θ¨ from geometrical and inertial
properties is finally obtained.
θ¨ =
−Fd rA +M g rP +mg rA cos(θ)
I + IB +mB r2A +M r
2
P
(A.5)
Asymptotic analysis of Eq. A.5 predicts two different regimes of motion: at
low angular velocities the contribution of viscous dissipation through Eq. A.7600
becomes negligible and the dynamics of bolus swallowing is driven by the applied
force and the inertia of the system, hence a constant angular acceleration is
predicted. Conversely, when the magnitude of the viscous force becomes of
the same order of magnitude of the moment of the driving force (M g rP ) the
numerator of Eq. A.5 vanishes and the motion of the bolus approaches constant605
values of angular velocity that justify the definition of Fd. The inertia of the
central rotating assembly was determined once for all with empty runs of the
device. Its value, being two orders of magnitude higher than that of the bolus
led Hayoun et al. to consider it through a constant multiplication factor γ > 1
to I in Eq. A.5. Similarly a constant Fmin was used to correct for the friction610
of the roller, as a minimum applied weight to the drive pulley of approx. 0.4 N
was needed for the roller to start moving. In light of these latter observations
the final form of Eq. A.5 was approximated by the following (Eq. A.6).
θ¨ =
−Fd rA + (M g − Fmin) rP +mB g rA cos(θ)
γ I + IB +mB r2A +M r
2
P
(A.6)
The viscous force Fd that appears in Eq. A.6 was assumed linearly propor-
tional to the bolus velocity, obtained multiplying its angular velocity θ˙ by the615
radial distance of the roller from the center of rotation rA=47 mm (Mowlavi
et al., 2016). A similar linear dependency holds at relatively low swallowing
velocities, as comprehensively investigated by Mowlavi et al. (Mowlavi et al.,
2016). A simple model for Fd based on a Poiseuille flow assumption was used
to predict the experimental bolus velocity profiles. Under this hypothesis, the620
bolus was idealized as cylindrical element of fluid of uniform cross section and
length L moving with an average velocity equal to the roller velocity ( ˙theta).
This is consistent to the experimental observation that the length of the bolus
is approximately constant during the flow. The resulting viscous force was com-
puted, considering the liquid viscosity µ, via Eq. A.7. The constant β = 3.23625
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was fitted on the experimental results to account for the system friction and is
independent of the applied load and the fluid considered.
Fd = β 8pi µL θ˙rA (A.7)
The theory above was then extended considering the additional drag due to
the particle interaction with the mean flow. Bungay and Brenner investigated
the case of close fitting particles in tubes (Bungay and Brenner, 1973), while630
Wang and Skalak (Wang and Skalak, 1969) studied the additional resistance
in the case of a train of equally spaced spheres. The extension to the flow of
spheroidal and cylindrical particles was presented by Chen and Skalak (Chen
and Skalak, 1970) and more recently comprehensively described by Pozrikidis
and Davis (Pozrikidis and Davis, 2013). Semi empirical correlations developed635
over a wide range of flow regimes in cylindrical tubes have also been proposed,
in particular in the study of the pipeline flow of elongated capsules (Charles,
1963). Following the latter approach, a simple mathematical model considered
the annular flow in the gap between the flowing solid (of cross sectional radius
Ri = d/2) and the pipe radius Re. In this geometry, the boundary conditions640
impose that the inner cylindrical solid (i.e. the solid oral dosage form) moves
longitudinally with velocity equal to that of the roller θ˙ rA, while a no-slip
condition was applied to the external shell (i.e. the plastic membrane in which
the bolus was contained).
Adapting the theory on experimental results in laminar flow conditions, El-645
lis found that the pressure drop experienced in transporting an infinitely long
cylindrical neutrally buoyant object without axial offset, can be related to the
pressure drop in a Poiseuille flow, with identical mean velocity, corrected by a
factor dependent upon of the ratio of radii k = Ri/Re of the suspended solid
and the pipe (Ellis, 1964). On this basis, the same correction was applied to650
relate the viscous dissipation of the bolus flow in presence of solid oral dosage
forms to that of a Poiseuille flow.
Fd =
(
1− k4)−1β 8pi µL θ˙rA (A.8)
Eq. A.8 is consistent with the theory presented by Hayoun et al. when the
cross sectional size of the tablet vanishes.
Finally, the flow of multiple suspended solids of volume fraction φ was mod-655
eled considering a correction term to the viscosity of the liquid carrier (µ) ob-
tained from the Krieger-Dougherty model for spherical particles (Eq. A.9).
Fd = β 8pi µ
(
1− φ
φm
)−2.5 φm
L θ˙ rA (A.9)
The solid volume fraction φm was considered that of a random close packing
of particles (φm=0.64) (Hiemenz and Rajgopalan, 1997).
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